Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calendula ointment versus placebo/fluocortolone for prevention of radiation-induced breast skin erythema
2008-002202-18Phase 2Completed
- Sponsor
- Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano
- Start
- Jan 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in breast cancer comparing Calendula pomade with Placebo cream with rescue fluocortolone (2 arms). Primary endpoints: Acute cutaneous toxicity grade 2 prevention, Grade 2 erythema prevention and 1 more. Started Jan 2010; status: completed.
02
Drugs
calendulaFluocortolone
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2008-002202-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002202-18.